SEC Filings for Novavax Inc. (NVAX)

$ 46.30   1.64 (+3.67%) Volume: 8.08m 4:00 PM EDT 5-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/05/2020
SC 13GStatement of acquisition of beneficial ownership by individuals1006/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/29/2020
4Statement of changes in beneficial ownership of securities105/20/2020
8-KCurrent report pursuant to Section 13 or 15(d)4005/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)3305/18/2020
424B5Prospectus [Rule 424(b)(5)]2405/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)605/15/2020
DEFA14AAdditional proxy soliciting materials - definitive305/13/2020
DEF 14AOther definitive proxy statements8505/13/2020
8-KCurrent report pursuant to Section 13 or 15(d)1005/12/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)4505/11/2020
10-K/A[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]4804/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)1703/24/2020
4/A[Amend] Statement of changes in beneficial ownership of securities103/24/2020
<<
First
<
Prev
123456789101112131415